Predictive value of eTag dimerization assay in patients with metastatic colorectal cancer treated with erlotinib.

被引：0
|
作者：
Oza, AM
Townsley, CA
Pond, G
Singh, S
Siu, LL
机构：
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[2] Aclara Inc, Mountain View, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：865S / 865S
页数：1
相关论文
共 50 条
  • [1] Molecular network analysis of signaling pathways in metastatic breast cancer in patients treated with erlotinib.
    Speer, R.
    Wallwiener, D.
    Yang, S. X.
    Swain, S. M.
    Wulfkuhle, J. D.
    Liotta, L. A.
    Petricoin, E. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 556S - 556S
  • [2] Proteinuria as a predictive factor in metastatic colorectal cancer patients treated with bevacizumab
    Uysal, Mukremin
    Bozcuk, Hakan Sat
    Goksu, Sema Sezgin
    Tatli, Ali Murat
    Arslan, Deniz
    Gunduz, Seyda
    Coskun, Hasan Senol
    Ozdogan, Mustafa
    Savas, Burhan
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Predictive value of VEGF gene polymorphisms in metastatic colorectal cancer patients treated with a bevacizumab-based chemotherapy.
    Ulivi, Paola
    Marisi, Giorgia
    Scarpi, Emanuela
    Passardi, Alessandro
    Ragazzini, Angela
    Frassineti, Giovanni Luca
    Zoli, Wainer
    Valgiusti, Martina
    Nanni, Oriana
    Calistri, Daniele
    Casacci, Fabio
    Amadori, Dino
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] Predictive Value of Early Tumor Shrinkage and Density Reduction of Lung Metastases in Patients With Metastatic Colorectal Cancer Treated With Regorafenib
    Vanwynsberghe, Hannes
    Verbeke, Xander
    Coolen, Johan
    Van Cutsem, Eric
    CLINICAL COLORECTAL CANCER, 2017, 16 (04) : 377 - 380
  • [5] Phase II study of capecitabine, oxaliplatin and erlotinib in previously treated patients with metastatic colorectal cancer (MCRC).
    Meyerhardt, JA
    Xhu, A
    Enzinger, PC
    Ryan, DP
    Clark, JW
    Kulke, MH
    Michelini, A
    Vincitore, M
    Thomas, A
    Fuchs, CS
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 265S - 265S
  • [6] Prognostic Value of Sarcopenia in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil
    Malik, Mateusz
    Michalak, Maciej
    Radecka, Barbara
    Gelej, Marek
    Jackowska, Aleksandra
    Filipczyk-Cisarz, Emilia
    Hetman, Katarzyna
    Foszczynska-Kloda, Malgorzata
    Kania-Zembaczynska, Beata
    Manka, Danuta
    Orlikowska, Marlena
    Rogowska-Dros, Hanna
    Bodnar, Lubomir
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
  • [7] Neutropenia as a predictive factor in patients with metastatic colorectal cancer treated with TAS-102
    Hamauchi, S.
    Yamazaki, K.
    Masuishi, T.
    Kito, Y.
    Komori, A.
    Tsushima, T.
    Todaka, A.
    Yokota, T.
    Machida, N.
    Fukutomi, A.
    Onozawa, Y.
    Muro, K.
    Yasui, H.
    Mori, K.
    Taniguchi, H.
    ANNALS OF ONCOLOGY, 2015, 26 : 50 - 51
  • [8] Prognostic and Predictive Value of HER2 Amplification in Patients With Metastatic Colorectal Cancer
    Sawada, Kentaro
    Nakamura, Yoshiaki
    Yamanaka, Takeharu
    Kuboki, Yasutoshi
    Yamaguchi, Daisuke
    Yuki, Satoshi
    Yoshino, Takayuki
    Komatsu, Yoshito
    Sakamoto, Naoya
    Okamoto, Wataru
    Fujii, Satoshi
    CLINICAL COLORECTAL CANCER, 2018, 17 (03) : 198 - 205
  • [9] The predictive value of primary tumor location in patients with metastatic colorectal cancer: A systematic review
    Boeckx, Nele
    Janssens, Katleen
    Van Camp, Guy
    Rasschaert, Marika
    Papadimitriou, Konstantinos
    Peeters, Marc
    Op de Beeck, Ken
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 121 : 1 - 10
  • [10] Predictive and prognostic value of KRAS mutations in metastatic colorectal cancer patients treated with cetuximab: A meta-analysis of 22 studies
    Qiu, Li-Xin
    Mao, Chen
    Zhang, Jian
    Zhu, Xiao-Dong
    Liao, Ru-Yan
    Xue, Kai
    Li, Jin
    Chen, Qing
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (15) : 2781 - 2787
12345